SCHEMBL1502438

SCHEMBL1502438

O=C(Cl)CCCI

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4019339 0.91
SCHEMBL28024649 0.88
SCHEMBL2767830 0.80
SCHEMBL132364 0.79 TSHR (0.67)
SCHEMBL180666 0.79
SCHEMBL496221 0.76 TSHR (0.72)
SCHEMBL2154814 0.76 TSHR (0.72)
SCHEMBL494288 0.76 TSHR (0.72)
SCHEMBL2154041 0.76 TSHR (0.72)
Hydrochloric Acid SCHEMBL7947881 0.76 TSHR (0.63)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120040379-A Method for synthesizing photoinitiator 389 兰州大学 2025-05-27 CN claimed
CN-101993358-A A process for producing 4-(4-halo-1-oxybutyl)-alpha,alpha-dimethylbenzene acetic acid or alkyl esters thereof JUBILANT ORGANOSYS LTD 2011-03-30 CN claimed
EP-2289867-A2 A process for producing 4-(4-halo-1-oxybutyl)-alpha,alpha-dimethylbenzene acetic acid or alkyl esters thereof Jubilant Organosys Limited (IN) 2011-03-02 EP claimed
CN-120040379-A Method for synthesizing photoinitiator 389 兰州大学 2025-05-27 CN disclosed
CN-115715219-A Water soluble, modified amino acid derivatives for the treatment of neurological diseases and selected psychiatric disorders 雅盖隆大学 2023-02-24 CN disclosed
CN-114588278-A fluorescence-CT bimodal molecular probe, preparation method and application thereof 康达洲际医疗器械有限公司 2022-06-07 CN disclosed
US-10056638-B2 Phosphonium cations and polymers incorporating them UNIVERSITY OF DELAWARE (US) 2018-08-21 US disclosed
US-20170149080-A1 PHOSPHONIUM CATIONS AND POLYMERS INCORPORATING THEM UNIVERSITY OF DELAWARE (US) 2017-05-25 US disclosed
US-20170149080-A1 PHOSPHONIUM CATIONS AND POLYMERS INCORPORATING THEM UNIVERSITY OF DELAWARE (US) 2017-05-25 US disclosed
US-20170149080-A1 PHOSPHONIUM CATIONS AND POLYMERS INCORPORATING THEM UNIVERSITY OF DELAWARE (US) 2017-05-25 US disclosed
WO-2012056294-A1 AN IMPROVED PROCESS FOR THE PREPARATION OF N-PENTANOYL-N-[[2'-(1H-TETRAZOL-5-YI)[1,1'-BIPHENYL]-4-YI]METHYL]-L-VALINE JUBILANT LIFE SCIENCES LTD. (IN) 2012-05-03 WO disclosed
US-20120101048-A1 COMPOUNDS FOR ENZYME INHIBITION ONYX THERAPEUTICS, INC. (US) 2012-04-26 US disclosed
CN-101993358-A A process for producing 4-(4-halo-1-oxybutyl)-alpha,alpha-dimethylbenzene acetic acid or alkyl esters thereof JUBILANT ORGANOSYS LTD 2011-03-30 CN disclosed
EP-2289867-A2 A process for producing 4-(4-halo-1-oxybutyl)-alpha,alpha-dimethylbenzene acetic acid or alkyl esters thereof Jubilant Organosys Limited (IN) 2011-03-02 EP disclosed
US-20100256128-A1 GAMMA SECRETASE MODULATORS SCHERING CORPORATION (US) 2010-10-07 US disclosed
WO-2009034059-A2 AZO QUINOLINIUM COMPOUNDS COMPRISING A DISULPHIDE/THIOL UNIT, COMPOSITIONS CONTAINING SAME, PROCESS FOR DYEING KERATIN FIBRES AND DEVICE L'OREAL (FR) 2009-03-19 WO disclosed
US-20070135426-A1 LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2007-06-14 US disclosed
US-5089485-A ANTI-INFLAMMATORY FURANONES ALLERGAN, INC. (US) 1992-02-18 US disclosed
EP-0369811-A2 Anti-inflammatory furanones ALLERGAN, INC (US) 1990-05-23 EP disclosed